APC's statement on HHS's interim enforcement discretion policy for six peptides
HHS is allowing compounding of six peptides under interim enforcement discretion. APC explains the guardrails, limits, and what happens next.
Being an exceptional compounding professional means you never stop learning
We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
HHS is allowing compounding of six peptides under interim enforcement discretion. APC explains the guardrails, limits, and what happens next.
Want to teach compounding owners something new? APC is seeking Owner Summit 2027 presenters. Practical sessions only, no sales pitches. Due November ...
NJ Assembly Health Committee heard from pharmacists on GLP-1 safety and access. APC and NJPhA urged action on illicit products, not lawful ...
RFK Jr. wants a state-regulated peptide marketplace centered on 503A pharmacies. Sen. Marshall urges FDA enforcement discretion. APC seeks guardrails.
APC CEO Scott Brunner joins the Hims House podcast to discuss peptides, FDA uncertainty, APC’s proposed guardrails, and two meetings with the agency.
Unapproved obesity drug spawns a black market frenzy